Tachycardia
Navigation Links
Tachycardia in Medical News
Cordex Pharma Files ATPace Formulation Patent
... acute management of paroxysmal supraventricular tachycardia (PSVT) as well as a diagnostic test for the ... have been clinically used to terminate tachycardia in certain cases. "We are very pleased with ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ...Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
... have been clinically used to terminate tachycardia in certain cases. About Cordex Pharma, Inc. ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ... for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, the ...... and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. ... About Ventricular Fibrillation and Ventricular tachycardia Ventricular fibrillation is a condition in ... help is provided immediately. Ventricular tachycardia is a fast or rapid heart rate that starts in ...
Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial and CDP-1050's expected ...Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected ...Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
... of a frequent cardiac arrhythmia called paroxysmal supraventricular tachycardia (PSVT). On April 16, 2008, Duska met with the FDA and confirmed that a ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and Duska's CDP-1050 is expected to commence a Phase 2 clinical trial for ...Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
... clinical trials evaluating its lead product ATPace(TM) as an antiarrhytmic drug for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT) under the Special Protocol Assessment (SPA) process. ATPace(TM) is a novel stable liquid formulation of adenosine 5'-triphosphate (ATP). ...Expert consensus on catheter ablation of ventricular arrhythmias
... tachycardias that originate from the epicardial surface of the heart. The delineation of the relation between cardiac anatomy and focal ventricular tachycardia origins in the right and left ventricular outflow tracts and papillary muscles. ...Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009
... daily clinical practice and scientific discovery. This year we are seeing an important increase in utilization for applications such as ventricular tachycardia and navigation of the unpredictable anatomy associated with congenital heart disease. Our customers report that magnetic navigation is uniquely ...... ablation of atrial fibrillation. He has published numerous articles, most famously a seminal multi-center clinical trial on ventricular tachycardia ablation. Known as SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia), the study examined the use of ...
Tachycardia in Medical Technology
Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
... for the treatment of paroxysmal supraventricular tachycardia (PSVT). Under the agreement, a portion of Cato's ... have been clinically used to terminate tachycardia in certain cases. Cordex has submitted its ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ...Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement ...Duska Therapeutics Applies for Phase 3 Special Protocol Assessment
... atrio-ventricular nodal conduction, have been clinically used to terminate tachycardia in certain cases. "The request for a SPA represents a significant ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in Q1 2009. Duska's CDP-1050 is expected to commence a Phase 2 clinical ...... Reduction in tachycardia and Blood Acetaldehyde Levels in Subset of Subjects with Inborn Error of ... acetaldehyde levels produce acute symptoms, including facial flushing, tachycardia (rapid heart rate), headache, nausea and dizziness. Although ALDH2 ...
... vs. 4% placebo), hot flush (11% vs. 4% placebo), dizziness (11% vs. 5% placebo), hyperhidrosis (8% vs. 1% placebo), palpitations (7% vs. 3% placebo), tachycardia (5% vs. 1% placebo), and hypertension (5% vs. 1%). Overall premature discontinuation rates (all causes including adverse event related) ...
... incidence (%) in these 98 patients: hypotension (50%), back pain (30%), dyspnea (28%), vasodilation (28%), rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%), or anaphylaxis (1%). These events were severe in 2% of patients. -- ...
Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
... serious health disorders. In addition to the long-term health risks, elevated acetaldehyde levels produce acute symptoms, including facial flushing, tachycardia (rapid heart rate), headache, nausea and dizziness. Although ALDH2 deficient people suffer from unpleasant reactions and face long-term health ...... tolerated in all phases of study. Adverse events were mild to moderate in severity and included chills, fever, nausea, vomiting, myalgia, headache, tachycardia (fast heart rate), hypo- and hypertension, fatigue and shortness of breath, all of which are consistent events with the activation of monocytes ...
... tolerated in all phases of study. Adverse events were mild to moderate in severity and included chills, fever, nausea, vomiting, myalgia, headache, tachycardia (fast heart rate), hypo- and hypertension, fatigue and shortness of breath, all of which are consistent events with the activation of monocytes ...
... challenge, some subjects exhibited transient symptoms consistent with volume depletion and/or vasodilatation including dizziness, asymptomatic tachycardia and orthostatic hypotension. These events are indicative of a practical limit of pharmacologic activity in normal healthy subjects, and Nile intends ...
Tachycardia in Medical Products
Description:... Jude Medical's universal programmer platform, the Model 3510 programming system, is used in combination with St. Jude Medical® bradycardia and tachycardia devices, including products for emerging indications. Features a large, color display on a touch-sensitive, active matrix LCD screen Programmer ...
Company:St. Jude Medical, Inc.
Description:... System Analyzer (PSA Wand), model 3150, offers an integrated solution for implantation testing, programming and interrogation of bradycardia and tachycardia devices. Designed as an easy-to-use accessory to the St. Jude Medical model 3510 programmer Facilitates implantation testing by obtaining ...
Company:St. Jude Medical, Inc.
Company:Boston Scientific Corporation
Description:... also experience atrial fibrillation. Painless antitachycardia pacing (ATP) therapy to terminate three-out-of-four episodes of fast ventricular tachycardia (VT)47 Enhanced PR Logic dual-chamber detection achieving 95.2% accuracy (positive predictive value - PPV) in delivered therapies48 The ...
Company:Medtronic Inc.
Description:... against cardiac remodeling. Tupos LA uses biatrial stimulation to effectively suppress the typical symptomatic and medicine resistant atrial tachycardia of patients with interatrial blockages. The system is simple and quick to ....
Company:Biotronik GmbH & Co.
Description:... or left ventricle only to synchronize ventricular contractions. The device provides ventricular tachyarrhythmia therapy to treat ventricular tachycardia (VT) and ventricular fibrillation (VF), rhythms that are associated with sudden cardiac death ....
Company:Guidant Corporation
Description:... A dual chamber sensing/pacing, rate responsive, 31 J ICD, with ELA's patented PARAD/PARAD+ ventricular tachycardia ....
Company:ELA Medical, Inc.
Description:... A single chamber sensing/pacing, rate responsive, 31 J ICD, with a full range of ventricular tachycardia ....
Company:ELA Medical, Inc.
Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation
Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation
Company:St. Jude Medical, Inc.
Description:... System Analyzer (PSA Wand), model 3150, offers an integrated solution for implantation testing, programming and interrogation of bradycardia and tachycardia devices. Designed as an easy-to-use accessory to the St. Jude Medical model 3510 programmer Facilitates implantation testing by obtaining ...
Company:St. Jude Medical, Inc.
Chilli II Cooled Ablation Catheters
Description:... performance of the Boston Scientific Blazer(R) catheter platform. Cooled cardiac ablation is a recent advancement in the treatment of ventricular tachycardia (VT) using radio frequency (RF) energy. VT is a serious cardiac arrhythmia characterized by heart rates above 100 beats per minute. The Boston ...Company:Boston Scientific Corporation
Description:... also experience atrial fibrillation. Painless antitachycardia pacing (ATP) therapy to terminate three-out-of-four episodes of fast ventricular tachycardia (VT)47 Enhanced PR Logic dual-chamber detection achieving 95.2% accuracy (positive predictive value - PPV) in delivered therapies48 The ...
Company:Medtronic Inc.
Description:... against cardiac remodeling. Tupos LA uses biatrial stimulation to effectively suppress the typical symptomatic and medicine resistant atrial tachycardia of patients with interatrial blockages. The system is simple and quick to ....
Company:Biotronik GmbH & Co.
Description:... or left ventricle only to synchronize ventricular contractions. The device provides ventricular tachyarrhythmia therapy to treat ventricular tachycardia (VT) and ventricular fibrillation (VF), rhythms that are associated with sudden cardiac death ....
Company:Guidant Corporation
Description:... A dual chamber sensing/pacing, rate responsive, 31 J ICD, with ELA's patented PARAD/PARAD+ ventricular tachycardia ....
Company:ELA Medical, Inc.
Description:... A single chamber sensing/pacing, rate responsive, 31 J ICD, with a full range of ventricular tachycardia ....
Company:ELA Medical, Inc.
Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation
Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation
Tachycardia in Medical Definition
... - Long QT syndrome - Cardiac arrest - tachycardia ( Supraventricular tachycardia , AV nodal reentrant tachycardia , ...
... abnormal beats. If these concurrent beats number three, they are called triplets and are considered as a brief run of non-sustained Ventricular tachycardia or NS-VT. PVC's are not the only aberrant beat that makes use of these adjectives; others are premature atrial contractions , parasystole , and ...
... abnormal beats. If these concurrent beats number three, they are called triplets and are considered as a brief run of non-sustained Ventricular tachycardia or NS-VT. PVC's are not the only aberrant beat that makes use of these adjectives; others are premature atrial contractions , parasystole , and ...
Tachycardia in Medical Dictionary
... Arrhythmia s can be divided into 2 main groups: tachycardia s and bradycardia s. tachycardia s cause a rapid heartbeat , with over 100 beats ... s may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ...
... Arrhythmias can be divided into 2 main groups: tachycardia s and bradycardia s. tachycardia s cause a rapid heartbeat , with over 100 beats ... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ...
... l fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... atria The ... (GS 840) See Preveon. Paroxysm al atria l tachycardia (PAT) and paroxysm al supra ...
... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... such as atrial fibrillation , supra ventricular tachycardia , or sinus ...
... ( Coronary Heart Disease ) ... Examples of tachycardia s may include a fast, irregular heart rhythm ... currently in sinus rhythm. Supra ventricular tachycardia Atrial flutter Rare types of ventricular tachycardia More recently, doctors have used catheter ...
... the Middle - Normal Heart Rhythm - Ventricular tachycardia ... 4 - Bradycardia is when the heart ... greater than 100 beats per minutes is called a tachycardia . If your heart rate is too fast (known as a tachycardia ), too slow (known as a bradycardia ) or very ...
... . Cardioversion . If you have an atria l tachycardia , including atrial fibrillation , your doctor ... such as atrial fibrillation , supra ventricular tachycardia , or sinus tachycardia . You may need medicine, electrical ...
... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... as atrial fibrillation , supra ventricular tachycardia , or sinus ...
... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ... pacemaker s. Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Wolff- Parkinson -White syndrome Sinus ...
... ) Supinator ( High Arch es) Supra ventricular tachycardia ( Paroxysm al Supra ventricular tachycardia ) SVT ( Paroxysm al Supra ventricular tachycardia ) Swayback ( Lordosis ) ... ...
... Arrhythmias can be divided into 2 main groups: tachycardia s and bradycardia s. tachycardia s cause a rapid heartbeat , with over 100 beats ... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ...
... l fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... atria The ... (GS 840) See Preveon. Paroxysm al atria l tachycardia (PAT) and paroxysm al supra ...
... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... such as atrial fibrillation , supra ventricular tachycardia , or sinus ...
... ( Coronary Heart Disease ) ... Examples of tachycardia s may include a fast, irregular heart rhythm ... currently in sinus rhythm. Supra ventricular tachycardia Atrial flutter Rare types of ventricular tachycardia More recently, doctors have used catheter ...
... the Middle - Normal Heart Rhythm - Ventricular tachycardia ... 4 - Bradycardia is when the heart ... greater than 100 beats per minutes is called a tachycardia . If your heart rate is too fast (known as a tachycardia ), too slow (known as a bradycardia ) or very ...
... . Cardioversion . If you have an atria l tachycardia , including atrial fibrillation , your doctor ... such as atrial fibrillation , supra ventricular tachycardia , or sinus tachycardia . You may need medicine, electrical ...
... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... as atrial fibrillation , supra ventricular tachycardia , or sinus ...
... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ... pacemaker s. Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Wolff- Parkinson -White syndrome Sinus ...
... ) Supinator ( High Arch es) Supra ventricular tachycardia ( Paroxysm al Supra ventricular tachycardia ) SVT ( Paroxysm al Supra ventricular tachycardia ) Swayback ( Lordosis ) ... ...
Tachycardia in Biological News
Targeted drug therapy prevents exercise-induced arrhythmias
... risk for sudden death, but ongoing arrhythmias can result in frequent stressful shocks. The Dutch patient, for example, experienced ventricular tachycardia and ICD shocks whenever he got out of bed, Knollmann said. Defibrillator therapy also can be problematic for pediatric patients (CPVT is usually ...Studies point to novel target for treating arrhythmias
... The researchers examined the heart rhythms of mice expressing various troponin mutants that cause HCM and showed that the mice develop ventricular tachycardia (a particular arrhythmia). The risk for this arrhythmia was directly related to the degree of calcium sensitization caused by the troponin mutation: ...Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
... Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB ...Fish oil -- helpful or harmful?
... such as men with stable angina. The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are not taking antiarrhythmic medications. Fish oils have promise as beneficial in cardiovascular disease but our work highlights our gaps ...University of Pittsburgh cardiologists identify new cardiac arrest gene
... lead to less current flow and shorter heart beats in a part of the heart. This puts patients at risk for rapid heart rhythms such as ventricular tachycardia and fibrillation. Symptoms often present with no warning, and the seemingly healthy patient passes out and/or suffers a sudden cardiac arrest from an ...Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure
... to understand the characteristics of ventricular tachycardia -- a condition characterized by abnormally fast ... death can result within minutes. "Ventricular tachycardia and fibrillation are the leading causes of sudden ... engineered tissues as would occur in ventricular tachycardia and attempted to halt it with pace-setting ....Researchers link two more genes to sudden infant death syndrome
... gene. RyR2 was targeted because of its involvement in a distinct genetic heart rhythm disease known as catecholaminergic polymorphic ventricular tachycardia (CPVT). "For a parent whose infant died suddenly and mysteriously even five years ago, we were essentially unable to provide them with a cause and ...Tachycardia in Biological Technology
Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
... with paroxysmal supraventricular tachycardia (PSVT). PSVT is a condition characterized ... for the treatment of paroxysmal supraventricular tachycardia in Q1 2009. Duska's CDP-1050 is expected to ... for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, Duska's ...Cordex Pharma Forms Heart Failure Medical Advisory Board
... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected ...Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement ...Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment
... is a proposed product for the termination of paroxysmal supraventricular tachycardia (PSVT). The bradycardic effect of ATP, in particular its blockade of ... patients presenting to the emergency room with paroxysmal supraventricular tachycardia (PSVT) should be sufficient to demonstrate clinical safety and efficacy, ...Cordex Completes Production of ATPace(TM) Clinical Trial Material
... Research, Inc. The CTM will be used in the planned clinical trials for the acute treatment of patients presenting with paroxysmal supraventricular tachycardia (PSVT) in the emergency room. Several formulations of ATP have been used in Europe for over five decades as the drug of choice for the acute ...Stereotaxis Showcases Advancements for Remote Magnetic Ablations
... partnered magnetic irrigated catheter, now available in Europe, is widely recognized as the gold standard for complex ablations such as ventricular tachycardia and complex left atrial arrhythmias. European clinicians have treated more than 600 patients with the magnetic irrigated catheter, with extremely ...... includes new language noting that there was a significantly lower incidence of arrhythmias (ventricular tachycardia, bradycardia, supraventricular tachycardia and new atrial fibrillation) in patients treated with Ranexa versus placebo. This difference in arrhythmias did not lead to a reduction in mortality, ...
Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
... with embedded algorithms that automatically detect, record and immediately transmit asymptomatic events such as atrial fibrillation, bradycardia, tachycardia and cardiac pause. A photo of the ER920W is available at http://www.biotelinc.com/images/BraemarER920W.jpg . Braemar, Inc., designs, develops, ...CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
... Less frequent side effects reported in patients administered Adenoscan include second and third degree AV block, fatal cardiac arrest, ventricular tachycardia and nonfatal myocardial infarction. For full prescribing information, please visit http://www.adenoscan.com . About CV Therapeutics CV ...Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
... Ranexa compared to placebo in the MERLIN TIMI-36 study. Patients receiving Ranexa had a 37 percent reduction in their relative risk of ventricular tachycardia lasting eight beats or more (p<0.001) and there were fewer episodes of sudden cardiac death observed in patients taking ranolazine (56) than in ...Other ContentsparentingparentingadenomaadenomaadenomaparaplegiaparonychiaparenteralparenteralparenteralparesisparesthesiaOther TagsMerocel
(Date:12/2/2009)... , SAN DIEGO, Dec. 2 /PRNewswire-FirstCall/...resent at the 21st Annual Piper Jaffray Health Car...presentation is scheduled to be webcast live and m...tion of Gen-Probe,s website at www.gen-probe.com ...ing the event. ,, About Gen-Probe ,, Gen-...
(Date:12/2/2009)... , CHICAGO, Dec. 2 /PRNewswire-USNewswire/ -...f the breast, including lumps, is a safe, reliable...es for women under age 40, according to the findin...eting of the Radiological Society of North America...ultrasound, we can reduce the number of expensive ...
(Date:12/2/2009)...HICAGO Targeted breast ultrasound of suspicious a...liable and cost-effective alternative to invasive ...findings of two studies presented today at the ann...merica (RSNA). , "By performing high-quality bre...ive and avoidable invasive diagnostic procedures i...
(Date:12/1/2009)... Threaded Metal Housing Enab... Minneapolis, Minnesota (Vocus)...er in nano-miniature connectors, has announced the...eir nano family of products. These are the smalle...metal shell provides a positive lock while compres...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, The...utics - Market Forecasts to 2015, Competitive Benc..., http://www.reportlinker.com/p0166814/The-Futur...--Market-Forecasts-to-2015-Competitive-Benchmarkin...
Breaking Medicine News(10 mins):Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Omnetics Announces Newest Addition to Nano Circular Family 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22[0] Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today[0] Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty[0] Targeted breast ultrasound can reduce biopsies for women under 40[0] Omnetics Announces Newest Addition to Nano Circular Family [0] Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
(Date:11/30/2009)...BURGHA University of Pittsburgh team overcame a ma...ls such as those that could lead to more efficient... exhaust less toxic. The researchers reported Nov....of high-temperature stability in metallic nanopart...red by a vulnerability to extreme heat. , Gtz Ve...
(Date:11/30/2009)...rleans, LA Researchers from LSU Health Sciences C...Kennedy Shriver National Institute of Child Health...Public Health, Brigham and Women,s Hospital, and H...me that drinking more than 5 servings of sugar- sw...significantly elevate the risk of developing diabe...
(Date:11/30/2009)...ditors of The Journal of Experimental Biology ar...entre National de la Recherche Scientifique (CNRS)...winner of this year,s JEB Outstanding Paper Priz...tanding achievement and is intended to encourage y...ditor-in-Chief, and adds that ,we truly appreciate...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Mercury Levels Not Abnormal in Autistic Children 59764 1Mercury Levels Not Abnormal in Autistic Children 59764 2Mercury Levels Not Abnormal in Autistic Children 59764 3Resident physicians seldom trained in skin cancer examination 59762 1Resident physicians seldom trained in skin cancer examination 59762 2Pediatricians put proven treatment strategies to work against childhood asthma 59760 1Pediatricians put proven treatment strategies to work against childhood asthma 59760 2HolthAfterCareGuiborNitEyePallikarisGuiberUrettsSchockettHardtenYavitzChayettCleanFieldKERASPEARMerocel
Other Tagsalcoholic 2alcoholic 3alcoholic 4alcoholic 5alcoholic 6powerful 2powerful 3powerful 4powerful 5powerful 6powerful 7powerful 8powerful 9powerful 10voluntary 2voluntary 3voluntary 4voluntary 5voluntary 6voluntary 7voluntary 8voluntary 9voluntary 10minimized 2unprecedented 2unprecedented 3unprecedented 4unprecedented 5proteins 2proteins 3proteins 4proteins 5proteins 6proteins 7proteins 8proteins 9proteins 10relates 2successfully 2successfully 3successfully 4successfully 5successfully 6successfully 7successfully 8successfully 9successfully 10tool 2tool 3tool 4tool 5tool 6tool 7tool 8tool 9tool 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |